Commonwealth Equity Services’s Kailera Therapeutics KLRA Stock Holding History

Commonwealth Equity Services’s Portfolio KLRA Stock Details KLRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$134K	Buy	+11,713	New	+$198K	﹤0.01%	4174

Other funds holding KLRA

Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Mirador Capital Partners Pleasanton, California $859M AUM 41.74% 1-Year Est. Return

Everence Capital Management Goshen, Indiana $1.9B AUM 32.96% 1-Year Est. Return

Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Commonwealth Equity Services's KLRA Position: Q3 2026 in Review

Commonwealth Equity Services opened a new position in Kailera Therapeutics (KLRA) in Q3 2026: 11,713 shares worth $134K. The stake represents ﹤0.01% of the portfolio and ranks #4174 among its holdings.

24 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.

Commonwealth Equity Services held 11,713 shares of Kailera Therapeutics worth $134K as of Q3 2026.
Kailera Therapeutics was a new Commonwealth Equity Services position in Q3 2026.
Kailera Therapeutics made up ﹤0.01% of Commonwealth Equity Services's portfolio in Q3 2026, its #4174 holding.
24 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.

Based on Commonwealth Equity Services's 13F filing for Q3 2026, filed 2 Nov 2026.